In conclusion, CaM dissociation from RyR2 plays a crucial role in the pathogenesis of AD, and enhancing CaM binding to RyR2 may be a novel, potent therapeutic strategy against AD. This evidence concerns the gene RYR2 and Alzheimer disease.